A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting β-catenin and Twist1 degradation

Abstract Background The high mortality rate of metastatic colorectal cancer (CRC) is primarily attributed to resistance to chemotherapy, where cancer stem cells (CSCs) play a crucial role. Deubiquitinating enzymes are essential regulators of CSC maintenance, making them potential targets for elimina...

Full description

Bibliographic Details
Published in:Journal of Translational Medicine
Main Authors: Fengtian Li, Yi Zhou, Xinyue Lin, Yaxin Zhang, Qingyong Hu, Enen Zhao, Huali Li, Xingyan Pan, Feng Shu, Kun Zhang, Chengmei Huang, Na Tang, Wenting Liao
Format: Article
Language:English
Published: BMC 2025-01-01
Subjects:
USP4
Chemotherapy resistance
Cancer stem cells
β-catenin
Twist1
Small molecule inhibitor
Online Access:https://doi.org/10.1186/s12967-024-06001-0

Internet

https://doi.org/10.1186/s12967-024-06001-0

Similar Items